other

Updated:

UK Research and Innovation

UK Research and Innovation is a public body established in 2018 in Swindon, United Kingdom.

UK Research and Innovation

UK Research and Innovation is a public body established in 2018 in Swindon, United Kingdom. It focuses on funding and supporting research and innovation across various sectors. The company provides financial investment and strategic guidance for research and innovation projects, primarily serving academia, industry, and government entities within the UK.

General information

Firm type

other

Year founded

2018

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

Swindon

Corporate office

Swindon, United Kingdom

Additional offices

London, United Kingdom · Bristol, United Kingdom

Principals

Ottoline Leyser

Chief Executive

David Sweeney

Executive Chair, Research England

Andrew Millar

Executive Director, Corporate Services

Katherine Fletcher

Interim Director, People and Culture

Sector focus

Health & Life SciencesClimate & Clean EnergyAI, Data & DigitalPhysical Sciences & EngineeringBiologics & Drug DiscoveryInfrastructure

Frequently asked questions

What is UKRI's core mission?

UKRI aims to allocate public money to the highest-quality research and innovation across all disciplines in the UK. It funds discovery science, applied research, postgraduate training, and business innovation through its seven research councils and Innovate UK. The organization is tasked with ensuring the UK remains a global leader in science and technology (per the 2017 Act).

How does UKRI differ from a traditional family office or asset manager?

UKRI is a statutory non-departmental public body. It does not manage a pool of capital for a single family or endowment. Instead, it distributes roughly £8.6 billion annually in grants and contracts to universities, research institutes, and businesses. Its mandate is public-policy-driven, not return-seeking.

Does UKRI make direct equity investments or only grants?

UKRI is primarily a grant-maker. However, its subsidiary Innovate UK provides a mix of grants, loans, and innovation contracts. Through UKRI Technology Limited and other vehicles, it may take equity in spinout companies, but this is a small fraction of total spending — the dominant mechanism remains non-equity grants.

Who controls UKRI's strategic direction?

The UKRI Board sets overall strategy, subject to oversight from the Department for Science, Innovation and Technology. The Chief Executive, Ottoline Leyser, is the accountable officer to Parliament. Each of the seven councils retains significant independence in allocating its own budget within the UKRI framework.

Which sectors does UKRI fund most heavily?

Based on public spending data, the largest recipients by council budget are medical research (MRC), engineering and physical sciences (EPSRC), and science and technology facilities (STFC). Innovate UK's business-focused awards prioritize clean energy, AI, health-tech, and advanced manufacturing. UKRI's own priorities include net zero, AI and data, healthspan, and trusted resilient societies (per UKRI strategy, 2022).

How does a researcher or company apply for UKRI funding?

Applications are submitted through the UKRI Joint Electronic Submission (Je-S) system or the newer UKRI Funding Service. Most calls are discipline-specific, tied to individual councils. Innovate UK runs competitive competitions with defined topics. Peer-review panels chaired by senior academics assess proposals against excellence, impact, and fit to strategy.

Does UKRI operate internationally?

Primarily domestic. However, UKRI funds international collaborations through bilateral agreements with bodies like the US National Science Foundation, the EU Horizon Europe programme (now partially associated), and with institutions in Japan, India, and Brazil. A dedicated International team within UKRI coordinates this.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Swindon other profiles